Johnson & Johnson on Wednesday said it has won Food and Drug Administration fast-track designation for its proposed posdinemab treatment for Alzheimer's disease. J&J is investigating the internally ...

Fans of the late former President Jimmy Carter weren't happy to see Speaker Mike Johnson (R-LA) and Senate Majority Leader ...

Social media users responded with a stark reminder after House Speaker Mike Johnson (R-La.) on Tuesday positively talked up ...

Brandon Johnson often speaks of his concern for the welfare of Chicago’s children, usually in the context of seeking more taxpayer money for Chicago Public Schools and supporting higher wages and more ...

For instance, if you're interested in generating more passive income, you may want to buy more dividend stocks. Or if your portfolio's performance has been sluggish, you may want to add more growth ...

Deion Sanders’ leadership of the Colorado Buffaloes continues to draw attention, not only for the team's impressive 9-4 ...

The city of Greensboro has a new Mayor Pro Tempore. Greensboro City Council named fellow council member Marikay Abuzuaiter to the position at Tuesday's meeting. She replaces the late Yvonne Johnson, ...

JNJ has an attractive 3.41% dividend yield comparable to the yield on long-term bonds. Given the lack of price movement and ...

Johnson & Johnson (JNJ) closed at $146.18 in the latest trading session, marking a +1.75% move from the prior day. The stock outpaced the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a ...

The jury determined that Johnson & Johnson was negligent and that the company intentionally misrepresented the safety of its ...

Johnson & Johnson closed $22.62 below its 52-week high ($168.85), which the company achieved on September 4th.

Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...